FDA approves subcutaneous infliximab for inflammatory bowel disease.

Published Date: 24 Oct 2023

For patients with moderately to severely active Crohn's disease or ulcerative colitis, the approval offers an alternate route of administration for the medication.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cardiorespiratory fitness lowers the risk of colon, lung, and prostate cancer in MEN and lowers mortality from these diseases.

2.

Chemo causes lasting physical decline in breast cancer survivors

3.

VP Nominee Medical Records Breached; Queen Elizabeth's Cancer; Galaxy Gas Whippets

4.

Race, Geography Linked to Gaps in Prostate Cancer Care

5.

DNA origami offers more accurate imaging in the fight against pancreatic cancer


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot